控股股東非經營性資金佔用流程違規 會稽山收浙江證監局警示函
會稽山(601579.SH)公告,公司收到中國證券監督管理委員會浙江監管局《關於對精功集團有限公司及金良順採取出具警示函措施的決定》的行政監管措施決定書。浙江證監局表示,根據現場檢查及公司2019年半年度報告披露的情況,會稽山存在控股股東非經營性資金佔用。2019年1月,會稽山通過全資子公司浙江唐宋紹興酒有限公司向杭州永仁實業有限公司提供借款共計0.95億元,永仁實業系會稽山關聯方,且永仁實業將上述資金拆借給了公司。截至2019年3月29日,公司已歸還全部拆借資金,但上述事項會稽山未按相關規定履行內部決策程序及信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.